πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

United Therapeutics Europe Patents

Full USPTO pharma patent portfolio for United Therapeutics Europe β€” grant dates, expiration, and drug cross-links.

Patents
3,720
Expiring ≀24m
234

Quick answer

United Therapeutics Europe has 3,720 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 234 expire within 24 months β€” use filters for patent-cliff planning.

Page 48 of 78

  1. US 8283151

    Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8278272

    GLP-1, exendin-4, peptide analogs and uses thereof

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8278100

    Lasonolide compounds as reagents for inducing premature chromosome condensation and methods for treating disorders

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8278083

    Inactivated influenza virus compositions

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8278458

    Desferrithiocin polyether analogues

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8278246

    Biocontrol of storage maladies of potatoes by bacterial antagonists produced in co-culture

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8278348

    Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8273797

    Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8273724

    Melanoma antigens and their use in diagnostic and therapeutic methods

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8268323

    Conformationally stabilized HIV envelope immunogens

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8268890

    Method of treating ischemia/reperfusion injury with nitroxyl donors

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8268894

    Compositions and methods for the treatment of infectious diseases

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8268602

    Cellular and viral inactivation

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8268615

    Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8263091

    Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8263759

    Sets of probes and primers for the diagnosis of select cancers

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8258280

    Plasmodium vivax hybrid circumsporozoite protein and vaccine

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8257915

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8258106

    Immunostimulatory nucleic acid molecules

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8258278

    Methods and compositions for the treatment and prevention of cancer

    Expires Mon Aug 30 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8252538

    MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8252291

    Bacteriocins and novel bacterial strains

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8252545

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8252845

    Pterostilbene as an agonist for the peroxisome proliferator-activated receptor alpha isoform

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8252839

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8252550

    Targeting poly-Ξ³-glutamic acid to treat Staphylococcus epidermidis and related infections

    Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8246931

    Development of a quail embryo model for the detection of botulinum toxin

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8247183

    Compositions and methods for diagnosis and treatment of tumors

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8247228

    Method of inducing memory B cell development and terminal differentiation

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8247225

    DNA promoters and anthrax vaccines

    Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8242160

    Inhibitors of ubiquitin E1

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8241638

    Induction of an immune response against dengue virus using the prime-boost approach

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8242305

    Process to prepare treprostinil, the active ingredient in remodulin

    Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8236313

    Prevention of tissue ischemia, related methods and compositions

    Expires Mon Aug 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8232259

    Multiple CpG oligodeoxynucleotide and their use to induce an immune response

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8232255

    Methods for vaccinating against malaria

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8232379

    Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8232373

    Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8232316

    Compounds and methods for delivery of prostacyclin analogs

    Expires Mon Jul 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8227417

    HMGN polypeptides as immune enhancers and HMGN antagonists as immune suppressants

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8227443

    Silencing of CSN5 gene expression using interfering RNA

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8227438

    Suppressors of CpG oligonucleotides and methods of use

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8227446

    Oligodeoxynucleotide and its use to induce an immune response

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8227421

    Fluorinated GHRH antagonists

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8222225

    Method of treating pneumoconiosis with oligodeoxynucleotides

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8221768

    Chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8221764

    Secreted campylobacter flagella coregulated proteins as immunogens

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8216565

    GP100-specific T cell receptors and related materials and methods of use

    Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does United Therapeutics Europe have?

3,720 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do United Therapeutics Europe patents expire?

234 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.